Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3677290014 | Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
3677291013 | Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Is a | Carbidopa and entacapone and levodopa only product in oral dose form | true | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has precise active ingredient | Levodopa | true | Inferred relationship | Some | 2 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has BoSS | Carbidopa | true | Inferred relationship | Some | 3 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has precise active ingredient | Entacapone | true | Inferred relationship | Some | 1 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has precise active ingredient | Carbidopa | true | Inferred relationship | Some | 3 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has BoSS | Entacapone | true | Inferred relationship | Some | 1 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Is a | Carbidopa- and entacapone- and levodopa-containing product | false | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has active ingredient | Carbidopa | false | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has active ingredient | Levodopa | false | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has active ingredient | Entacapone | false | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has active ingredient | Carbidopa | false | Inferred relationship | Some | 1 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has BoSS | Carbidopa | false | Inferred relationship | Some | 1 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Some | 1 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 3 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 3 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 3 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has active ingredient | Levodopa | false | Inferred relationship | Some | 2 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has BoSS | Levodopa | true | Inferred relationship | Some | 2 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Some | 2 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has active ingredient | Entacapone | false | Inferred relationship | Some | 3 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has BoSS | Entacapone | false | Inferred relationship | Some | 3 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength numerator value | 200 | false | Inferred relationship | Some | 3 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has BoSS | Carbidopa | false | Inferred relationship | Some | 2 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength numerator value | 25 | false | Inferred relationship | Some | 2 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has BoSS | Levodopa | false | Inferred relationship | Some | 1 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Some | 1 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has active ingredient | Entacapone | false | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has active ingredient | Levodopa | false | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has active ingredient | Carbidopa | false | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has precise active ingredient | Levodopa | false | Inferred relationship | Some | 1 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has precise active ingredient | Entacapone | false | Inferred relationship | Some | 3 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Has precise active ingredient | Carbidopa | false | Inferred relationship | Some | 2 | |
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Is a | Carbidopa- and entacapone- and levodopa-containing product in oral dose form | false | Inferred relationship | Some | ||
Carbidopa 25 mg and entacapone 200 mg and levodopa 100 mg oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets